1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 11 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2017Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancerPaltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.
2013Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcriptionAbankwa, D.; Millard, S.; Martel, N.; Choong, C.; Yang, M.; Butler, L.; Buchanan, G.; Tilley, W.; Ueki, N.; Hayman, M.; Leong, G.
2015Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesChan, S.; Selth, L.; Li, Y.; Nyquist, M.; Miao, L.; Bradner, J.; Raj, G.; Tilley, W.; Dehm, S.
2013Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancerRavindranathan, P.; Lee, T.; Yang, L.; Centenera, M.; Butler, L.; Tilley, W.; Hsieh, J.; Ahn, J.; Raj, G.
2009A Novel Androgen Receptor Amino Terminal Region Reveals Two Classes of Amino/Carboxyl Interaction-Deficient Variants with Divergent Capacity to Activate Responsive Sites in ChromatinNeed, E.; Scher, H.; Peters, A.; Moore, N.; Cheong, A.; Ryan, C.; Wittert, G.; Marshall, V.; Tilley, W.; Buchanan, G.
2009Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancerPeters, A.; Buchanan, G.; Ricciardelli, C.; Bianco-Miotto, T.; Centenera, M.; Harris, J.; Jindal, S.; Segara, D.; Jia, L.; Moore, N.; Henshall, S.; Birrell, S.; Coetzee, G.; Sutherland, R.; Butler, L.; Tilley, W.
2012Dual roles of PARP-1 promote cancer growth and progressionSchiewer, M.; Goodwin, J.; Han, S.; Brenner, J.; Augello, M.; Dean, J.; Liu, F.; Planck, J.; Ravindranathan, P.; Chinnaiyan, A.; McCue, P.; Gomella, L.; Raj, G.; Dicker, A.; Brody, J.; Pascal, J.; Centenera, M.; Butler, L.; Tilley, W.; Feng, F.; et al.
2012An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activityMoore, N.; Buchanan, G.; Harris, J.; Selth, L.; Bianco-Miotto, T.; Hanson, A.; Birrell, S.; Butler, L.; Hickey, T.; Tilley, W.

Discover